Daniel A. Yerace - 27 Jan 2023 Form 4 Insider Report for Coeptis Therapeutics Holdings, Inc. (COEP)

Role
VP of Operations, Director
Signature
/s/ Daniel A. Yerace
Issuer symbol
COEP
Transactions as of
27 Jan 2023
Net transactions value
$0
Form type
4
Filing time
31 Jan 2023, 10:09:01 UTC
Previous filing
07 Nov 2022
Next filing
09 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction COEP Incentive Stock Options (right to buy) Award +200,000 200,000 27 Jan 2023 Common Stock 200,000 $1.60 Direct F1, F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On January 27, 2023, the reporting person received a grant of 200,000 incentive stock options, under the 2022 equity incentive plan.
F2 The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Global Market on the day of grant.
F3 Options will vest over 4 years, with the first 25% vesting on 12/31/23, and the balance vesting in equal quarterly installments over the succeeding three years, with the final options vesting on 12/31/26.
F4 Expiration date is ten years from the day of grant.